ArticleJAMA oncology2022

Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy-Reply.

Ran Jennifer Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.